GRANTS

BESTARI 2018

  • DR NURUL ALIMAH BINTI ABDUL NASIR
  • ELUCIDATION OF THE UNDERLYING MECHANISMS OF ACTION OF TOCOTRIENOL-RICH FRACTION (TRF) AGAINST RETINOPATHY IN STZ-INDUCED DIABETIC RATS 600-IRMI/DANA 5/3/BESTARI (P) (001/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • ASSOC. PROF. DR RENU AGARWAL
  • MECHANISMS OF THE PROTECTIVE EFFECT OF MAGNESIUM ACERYLTAURATE AGAINST ENDOTHELIN 1 INDUCED RGC APOPTOSIS IN RATS 600-IRMI/DANA 5/3/BESTARI (P) (003/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR MOHAMMAD JOHARI BIN IBAHIM
  • INVESTIGATION OF EOSINOPHIL GRANULE PROTEINS GENE EXPRESSION IN HUMAN BREAST CANCER CELL LINE RESISTANT TO GAMMA-RAY IRRADITATION: IN VITRO AND VIVO STUDIES 600-IRMI/DANA 5/3/BESTARI (P) (004/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR NOOR SHAFINA BINTI MOHD NOR
  • ELUCIDATION OF THE UNDERLYING MECHANISMS OF ACTION OF TOCOTRIENOL-RICH FRACTION (TRF) AGAINST RETINOPATHY IN STZ-INDUCED DIABETIC RATS 600-IRMI/DANA 5/3/BESTARI (P) (001/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR SALMI BINTI RAZALI
  • ENHANCING RESILIENCE AND EMPOWERING WOMEN AND GIRLS IN SHELTERS USING "PEACE FOR WOMEN" 600-IRMI/DANA 5/3/BESTARI (P) (007/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR SHARANIZA BINTI AB RAHIM
  • INVESTIGATION OF SPIRONOLACTONE IMMUNOSENSITIZATION ON NATURAL KILLER CELLS IN OSTEOSARCOMA CELLS LINE (MG-63) 600-IRMI/DANA 5/3/BESTARI (P) (011/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR SABRILHAKIM BIN SIDEK
  • OPTIMIZATION OF TOPICAL NANOEMULSION FORMULATION CONTAINING TOCOTRIENOL-RICH FRACTION (TRF) FOR OCULAR USE 600-IRMI/DANA 5/3/BESTARI (P) (012/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR NURUL ALIMAH BINTI ABDUL NASIR
  • EFFECTS OF PIPER SARMENTOSUM (KADUK) SUPPLEMENTATION ON METABOLIC SYNDROME 600-IRMI/DANA 5/3/BESTARI (P) (013/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR ALYAA RAJIH MAHMOOD AL-KHATEEB
  • DEVELOPMENT OF NEW/POTENTIAL 3D OSTEOSARCOMA CULTURE MODEL FOR FUTURE APPLICATION IN TRANSLATIONAL ANTI-TUMOR THERAPY 600-IRMI/DANA 5/3/BESTARI (P) (015/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR NADIA BINTI MOHD MUSTAFAH
  • IMMEDIATE HEALTH RISK AND BENEFIT OF SCUBA DIVING 600-IRMI/DANA 5/3/BESTARI (P) (016/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • DR YUHANIZA SHAFINIE BINTI KAMSANI
  • EFFECTS TO TOCTRIENOL RICH FRACTION ON IN VITRO EMBRYONIC DEVELOPMENT IN ASTHMA-INDUCED MICE 600-IRMI/DANA 5/3/BESTARI (P) (017/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • ASSOC PROF DR JESMINE KHAN
  • EFFECT OF BISPHENOL A ON THE SMALL INTESTINAL TIGHT JUNCTION PROTEIN CLAUDIN 2, 3, AND 4 IN PREGNANT RATS AND THEIR FETUSES 600-IRMI/DANA 5/3/BESTARI (P) (014/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • PROF DR HAPIZAH BINTI MD NAWAWI
  • Projek Penyelidikan Saringan Kesihatan UiTM 600-IRMI/DANA 5/3/BESTARI (KY) (001/2018)

  • Year of Grant Approval (Duration) : 1 Feb 2018 – 31 Jan 2020
  • DR HASIDAH BINTI ABDUL HAMID
  • COST EFFECTIVENESS OF THE FAMILIAL HYPERCHOLESTEROLAEMIA CASE ASCERTAINMENT TOOL (FAMCAT) AGAINST THE DUTCH LIPID AND SIMON BROOME CRITERIA IN IDENTIFYING FAMILIAL HYPERCHOLESTEROLAEMIA (FH) IN MALAYSIA PRIMARY CARE SETTING 600-IRMI/DANA 5/3/BESTARI (127/2018)

  • Year of Grant Approval (Duration) : 1 Jul 2018 – 30 Jun 2020
  • DR WAN NOR I'ZZAH BINTI WAN MOHAMAD ZAIN
  • POSSIBLE INVOLVEMENT OF TIGHT JUNCTION PROTEINS IN THE MECHANISMS OF ERBB1 TYROSINE KINASE INHIBITORS AFFECTING T84 HUMAN COLONIC EPITHELIAL PERMEABILITY 600-IRMI/DANA 5/3/BESTARI (132/2018)

  • Year of Grant Approval (Duration) : 1 Jul 2018 – 30 Jun 2020

MITRA 2018

  • PROF. DR. MUSALMAH BINTI MAZLAN
  • DEVELOPMENT OF ENHANCED FORMULATION OF PALM TOCOTRIENOL RICH FRACTION (ETRF) WITH PALM KERNEL OLEIN AS CARRIER FOR DIETARY SUPPLEMENTATION 600-IRMI/DANA 5/3/MITRA (P) (025/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • PROF. DR. MUSALMAH BINTI MAZLAN
  • INVESTIGATING THE SAFETY, BIOAVAILABILITY AND MECHANISM OF ACTION OF AN ENHANCED FORMULATION OF PALM TOCOTRIENOL RICH FRACTION (ETRF) WITH PALM KERNEL OLEIN CAPSULE ON PRECLINICAL MODELS OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 600-IRMI/DANA 5/3/MITRA (P) (027/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • PROF. DR. MUSALMAH BINTI MAZLAN
  • FICUS DELTOIDEA AS THERAPEUTIC SUPPLEMENT FOR METABOLIC SYNDROME AND PREVENTION OF ATHEROSCLEROSIS : IN VIVO BENEFITS AND COST - EFFECTIVENESS 600-IRMI/DANA 5/3/MITRA (P) (029/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019
  • PROF. DR. HAPIZAH BINTI MD NAWAWI
  • FICUS DELTOIDEA, METABOLIC SYNDROME, IMPAIRED GLUCOSE TOLERANCE, LIFESTYLE INTERVENTION, METFORMIN 600-IRMI/DANA 5/3/MITRA (P) (030/2018)

  • Year of Grant Approval (Duration) : 1 Jan 2018 – 31 Dec 2019 (extend to 1 Jul 2020)

LESTARI

  • DR ILHAM AMEERA BINTI ISMAIL
  • ASSOCIATION BETWEEN KNOWLEDGE, ATTITUDE AND WORK - RELATED QUALITY OF LIFE WITH UPTAKE OF CERVIVAL CANCER SCREENING AMONG PRINARY CARE HEALTHCARE WORKERS IN GOMBAK DISTRICT 600-IRMI 5/3/LESTARI (045/2018)

  • Year of Grant Approval : 1 Jul 2018 - 30 Jun 2020
  • DR KHASNUR BINTI ABD MALEK
  • LEVELS OF PHYSICAL ACTIVITY AMONG WITH T2DM ATTENDING PRIMARY CARE CLINIC IN SELYANG UITM CAMPUS AND ITS ASSOCIATED FACTORS. 600-IRMI 5/3/LESTARI (046/2018)

  • Year of Grant Approval : 1 Jul 2018 - 30 Jun 2020
  • DR HASIDAH BINTI ABDUL HAMID
  • EVALUATING THE PERFORMANCE OF THE FAMILIAL HYPERCHOLESTEROLAEMIA CASE ASCERTAINMENT TOOL (FAMCAT) IN IDENTIFYING FAMILIAL HYPERCHOLESTEROLAEMIA (FH) IN MALAYSIAN PRIMARY CARE SETTING 600-IRMI 5/3/LESTARI (047/2018)

  • Year of Grant Approval : 1 Jul 2018 - 30 Jun 2020
  • DR RUZI HAMIMI BINTI RAZALI
  • A PILOT STUDY : ASSOCIATION OF RS10965215 IN EXON 2 OF ANRIL WITH RISK OF MYOCARDIAL INFARCTION AND CORONARY ARTERY DISEASE 600-IRMI 5/3/LESTARI (048/2018)

  • Year of Grant Approval : 1 Jul 2018 - 30 Jun 2020
  • MDM SITI SHUHADA BINTI MOKHTAR
  • UNDERLYING MECHANISM OF OXIDISED HIGH DENSITY LIPOPROTEIN AND ADIPONECTIN ON BONE MINERALISATION 600-IRMI 5/3/LESTARI (049/2018)

  • Year of Grant Approval : 1 Jul 2018 - 30 Jun 2020

DUCS

  • NOR JANNAH NASUTION BINTI RADUAN
  • Burnout , Psychological Distress Job Satisfaction among UiTM Staff 600-UiTMSEL (PI. 5/4) (051/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • ROSNIDA BINTI MOHD NOH
  • Antibody Response To Booster Doses of Hepatitis B Vaccinated in Adults at Infancy 600-UiTMSEL (PI. 5/4) (052/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • ARJOANNA FARRA BINTI AZIZI
  • Identification of G264V mutation on AQP7 gene in obese subjects 600-UiTMSEL (PI. 5/4) (053/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • MARFU'AH BINTI NIK EEZAMUDDEEN
  • Examing the current practice of Giving Palliative Chemotherapy near the end of life in Malaysia 600-UiTMSEL (PI. 5/4) (054/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • NIK MUNIRAH BINTI NIK MOHD NASIR
  • Exploring the Usability and Feasibility of the Asthma Self-Management Book to Empower Adults with Asthma 600-UiTMSEL (PI. 5/4) (073/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • AB HALIM BIN SANIB @ MUSANNIP
  • Evaluation pf Protective effect of Vit E on the gross structure changes of Airways in Asthma-induced mice using Micro Computed Tomography with Histopathological Correlation 600-UiTMSEL (PI. 5/4) (055/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020

GIP

  • DR HEO CHONG CHIN
  • MITES ASSOCIATED WITH DECOMPOSING RABBIT CARCASSES 600-IRMI 5/3/GIP (017/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019 (extend 2/3/2020)
  • DR MUDIANA MUHAMAD @ MOHD SAUFI
  • HUMAN NOROVIRUS HOST CELL ENTRY IN M CELLS 3D CULTURE 600-IRMI 5/3/GIP (033/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019
  • DR SITI HAMIMAH SHEIKH ABDUL KADIR
  • ELUCIDATING THE ANTI-OXIDANT MECHANISM OF ENHANCED FORMULATION OF PALM TOCOTRIENOL RICH FRACTION (ETRF) USING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) MODEL 600-IRMI 5/3/GIP (053/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019 (extend 2/3/2020)
  • DR SUHAILA ABD MUID
  • UNDERLYING MECHANISMS OF OXIDISED HIGH DENSITY LIPOPROTEIN (OXHDL) AND ADIPONECTIN IN INDUCING OSTEOBLAST DECALCIFICATION 600-IRMI 5/3/GIP (055/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019
  • DR SYED BAHAROM SYED AHMAD FUAD
  • EFFECT OF GENESTEIN ON HUMAN CORONARY ARTERY ENDOTHELIAL CELLS INDUCED WITH OXIDISED LOW-DENSITY LIPOPROTEIN 600-IRMI 5/3/GIP (057/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019 (extend 2/3/2020)
  • AP DR FADZILAH MOHD NOR @ GHAZALI
  • GENETIC PROFILE CHARACTERIZATION OF MULTIDRUG RESISTANT CASETTE OF ACINETOBACTER BAUMANNI ISOLATES FROM HOSPITAL SUNGAI BULOH 600-IRMI 5/3/GIP (065/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019
  • PROF DR HAMIM RAJIKIN
  • EFFECTS OF NOCOTINE WITH SUPPLEMENTATION OF TOCOTRIENOL-RICH FRACTION ON CYTOSKELETAL STRUCTURE AND GENE EXPRESSION OF PREIMPLANTATION EMBRYO IN MICE 600-IRMI 5/3/GIP (083/2018)

  • Year of Grant Approval (Duration) : 1 Sep 2018 – 31 Aug 2019

External Grant

  • ASSOC PROF DR SITI HAMIMAH SHEIKH ABDUL KADIR
  • MOLECULAR INVESTIGATION OF THE NEWLY DEVELOPED WASTEWATER TREATMENT SYSTEM IN REMOVAL ITS DETRIMENTAL EFFECTS USING AN ANIMAL MODEL 100-IRMI/GOV 16/6/2 (002/2019)

  • Year of Grant Approval (Duration) : 1 Dec 2018 – 30 Nov 2020

INTERNATIONAL/PRIVATE GRANT

  • DR AHMAD IZUANUDDIN BIN ISMAIL
  • ONE YEAR HOSPITAL BASED SURVEILLANCE FOR INFLUENZA CASES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMATIC AND COMMUNITY ACQUIRED PNEUMONIA ADULT PATIENTS IN MALAYSIA 1100-IRMI/INT 16/6/2 (009/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2020
  • DR WAN NAJWA WAN MOHD ZOHDI
  • THE EFFECTIVENESS OF MANGOSTEEN SKIN PRODUCT (SPRAY8) ON DIABETIC WOUND HEALING (MASKID). 100-IRMI/PRI 16/6/2 (009/2018)

  • Year of Grant Approval (Duration) : 1 Feb 2018 – 1 Jan 2019
  • DR ANNAMALAI CHANDRA MOULI
  • AN ASIAN, PHASE 3, MULTICENTRE, RANDOMINZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 14-WEEK STUDY OF DS-5565 IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN FOLLOWER BY A 52- WEEK OPEN LABEL EXTENSION (REDUCER) 100-IRMI/PRI 16/6/2 (018/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Mac 2019
  • AHMAD IZUANUDDIN BIN ISMAIL
  • A PROSPECTIVE, MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE STUDY TO COMPARE THE EFFICACY AND THE SAFETY OF MASATINIB VERSUS PLACEBO IN THE TREATMENT OF PATIENTS WITH SEVERE UNCONTROLLED ASTHMA AND ELEVATED EOSINOPHIL LEVELS 100-IRMI/PRI 16/6/2 (010/2018)

  • Year of Grant Approval (Duration) : 1 Apr 2018 – 31 Dec 2022
  • PROF DR MUSALMAH MAZLAN
  • INVESTIGATING THE SAFETY, BIOAVAILABILITY AND MECHANISM OF ACTION OF AN ENCHANCED FORMULATION OF PALM TOCOTRIENOL RICH FRACTION(Etrf) WITH PALM KERNEL OLEIN CAPSULE ON PRECLINICAL MODELS OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 100-IRMI/PRI 16/6/2 (020/2018)

  • Year of Grant Approval (Duration) : 1 Aug 2018 – 31 Dec 2019